CABA
Price
$16.02
Change
-$0.03 (-0.19%)
Updated
Dec 1, 6:59 PM EST
101 days until earnings call
ORMP
Price
$2.13
Change
-$0.09 (-4.05%)
Updated
Dec 1, 6:59 PM EST
86 days until earnings call
Ad is loading...

Compare trend and price CABA vs ORMP

Header iconCABA vs ORMP Comparison
Open Charts CABA vs ORMPBanner chart's image
Cabaletta Bio
Price$16.02
Change-$0.03 (-0.19%)
Volume$718.64K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.13
Change-$0.09 (-4.05%)
Volume$60.94K
CapitalizationN/A
View a ticker or compare two or three
CABA vs ORMP Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CABA vs. ORMP commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Buy and ORMP is a Hold.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (CABA: $16.02 vs. ORMP: $2.13)
Brand notoriety: CABA and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 123% vs. ORMP: 77%
Market capitalization -- CABA: $801.28M vs. ORMP: $88.75M
CABA [@Biotechnology] is valued at $801.28M. ORMP’s [@Biotechnology] market capitalization is $88.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 1 green FA rating(s).

  • CABA’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 1 green, 4 red.
According to our system of comparison, CABA is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 6 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • CABA’s TA Score: 6 bullish, 4 bearish.
  • ORMP’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than CABA.

Price Growth

CABA (@Biotechnology) experienced а -14.19% price change this week, while ORMP (@Biotechnology) price change was -1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

CABA is expected to report earnings on Mar 14, 2024.

ORMP is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CABA with price predictions.
OPEN
A.I.dvisor published
a Summary for ORMP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CABA($801M) has a higher market cap than ORMP($88.7M). CABA YTD gains are higher at: 73.189 vs. ORMP (-82.294). ORMP has higher annual earnings (EBITDA): -15.96M vs. CABA (-66.37M). ORMP has more cash in the bank: 175M vs. CABA (164M). CABA has less debt than ORMP: CABA (4.27M) vs ORMP (76M). ORMP has higher revenues than CABA: ORMP (2.02M) vs CABA (0).
CABAORMPCABA / ORMP
Capitalization801M88.7M903%
EBITDA-66.37M-15.96M416%
Gain YTD73.189-82.294-89%
P/E RatioN/AN/A-
Revenue02.02M-
Total Cash164M175M94%
Total Debt4.27M76M6%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABAORMP
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PVADX12.580.39
+3.20%
Virtus NFJ Small-Cap Value Admin
SHWZ0.550.01
+1.49%
Medicine Man Technologies
JLVZX18.920.26
+1.39%
JPMorgan Large Cap Value R2
CBARX39.130.25
+0.64%
Calvert Balanced R6
SFRGY6.13-0.16
-2.62%
Salvatore Ferragamo SPA

CABA and

Correlation & Price change

A.I.dvisor tells us that CABA and CDTX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CABA and CDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+15.42%
CDTX - CABA
33%
Poorly correlated
+10.08%
ORMP - CABA
32%
Poorly correlated
-4.05%
ICVX - CABA
32%
Poorly correlated
+3.75%
PSTX - CABA
31%
Poorly correlated
-1.12%
IOVA - CABA
29%
Poorly correlated
+3.13%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with SRNEQ. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then SRNEQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.05%
SRNEQ - ORMP
51%
Loosely correlated
-2.49%
KRYS - ORMP
48%
Loosely correlated
+1.95%
VXRT - ORMP
48%
Loosely correlated
+2.08%
AGEN - ORMP
46%
Loosely correlated
+0.72%
MORF - ORMP
46%
Loosely correlated
+3.00%
More